CVKD (STOCKS)
Cadrenal Therapeutics, Inc. Common Stock
$3.350000
-0.350000 (-9.46%)
Prev close: $3.700000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Quang X. Pham
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $9.58M
- Employees
- 4
- P/E (TTM)
- -0.59
- P/B (TTM)
- 5.16
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
5
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-1.04 | $-1.65 | +0.6124 | +37.06% |
|
Dec 2025 (Q4)
|
$-1.43 | $-1.19 | -0.2417 | -20.34% |
|
Sep 2025 (Q3)
|
$-1.31 | $-1.56 | +0.2472 | +15.87% |
|
Jun 2025 (Q2)
|
$-1.87 | $-1.63 | -0.2414 | -14.82% |
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | $159.06K |
| Operating Expenses | $12.05M |
| Research and Development | $3.20M |
| Other Operating Expenses | $8.84M |
| Operating Income/Loss | -$12.05M |
| Income/Loss From Continuing Operations After Tax | -$11.89M |
| Income/Loss From Continuing Operations Before Tax | -$11.89M |
| Net Income/Loss | -$11.89M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$11.89M |
| Net Income/Loss Available To Common Stockholders, Basic | -$11.89M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$5.63 |
| Diluted Earnings Per Share | -$5.63 |
| Basic Average Shares | 6,456,394 |
| Diluted Average Shares | 6,456,394 |
| Assets | $2.86M |
| Current Assets | $2.86M |
| Noncurrent Assets | $6.79K |
| Fixed Assets | $4.62K |
| Other Non-current Assets | $2.17K |
| Liabilities | $1.06M |
| Current Liabilities | $1.06M |
| Accounts Payable | $824.81K |
| Other Current Liabilities | $240.14K |
| Noncurrent Liabilities | $0.00 |
| Equity | $1.80M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $1.80M |
| Liabilities And Equity | $2.86M |
| Net Cash Flow From Operating Activities | -$10.96M |
| Net Cash Flow From Operating Activities, Continuing | -$10.96M |
| Net Cash Flow From Investing Activities | $1.70M |
| Net Cash Flow From Investing Activities, Continuing | $1.70M |
| Net Cash Flow From Financing Activities | $5.93M |
| Net Cash Flow From Financing Activities, Continuing | $5.93M |
| Net Cash Flow | -$3.33M |
| Net Cash Flow, Continuing | -$3.33M |
| Comprehensive Income/Loss | -$11.89M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$11.89M |
| Other Comprehensive Income/Loss | $0.00 |